LAist is part of Southern California Public Radio (SCPR), a member-supported public media network. Hear our news on-air at our partner site:
In the largest ever multi-state consumer protection-based pharmaceutical settlement, California will receive $5.6 million--the largest share of the $62 Million, 32 state settlement--from medicine maker Eli Lilly and Company, the makers of antipsychotic drug Zyprexa. “Eli Lilly put profits ahead of patients when it marketed Zyprexa for a use that had not been properly tested or approved, in many cases, putting young women at risk for weight gain, hypoglycemia and even diabetes,” Attorney General Brown said a statement released today. Eli Lilly was accused of engaging "in unfair and deceptive practices when it marketed Zyprexa for off-label uses and [failing] to adequately disclose the drug’s potential side effects to healthcare providers."